Abbott Reports Third-Quarter 2025 Results and Reaffirms Full-Year Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Make sure you own this high-quality MedTech stock: RBC
October 17, 2025 4:00 PM EDTRBC Capital Markets reiterated its Outperform rating on one well-known MedTech stock in a note this week, calling it a high-quality company and saying it would be buyers following what it described as a quarter marked by transient headwinds.
The firm said Abbott's (NYSE: ABT) underlying business momentum is intact, even as the... More
Abbott (ABT) Reports In-Line Q3 EPS, Misses on Revenue; Offers FY25 EPS Guidance
October 15, 2025 7:32 AM EDTAbbott (NYSE: ABT) reported Q3 EPS of $1.30, in-line with the analyst estimate of $1.30. Revenue for the quarter came in at $11.37 billion versus the consensus estimate of $11.4 billion.
GUIDANCE:
Abbott sees FY2025 EPS of $5.12-$5.18, versus the consensus of $5.14.
For earnings history and earnings-related data on Abbott (ABT) click here.
... More